It's been a tumultuous year for U.S. stock markets. Investors have had their nerves rattled twice this year by government-related events—President Trump's Liberation Day tariffs in the spring, followed by the longest U.S. government shutdown in history this fall. That's on top of an economy already hit hard by inflation and declining consumer confidence. Yet despite this, there have still been several high-profile and successful initial public offerings throughout the year—especially in the AI and fintech s ...

Medline stock made a blockbuster debut on Wednesday with its IPO listing at $29 per share. The company raised roughly $6.26 billion and hit the public markets with an implied valuation near $50 billion, making it the year's biggest listing. The Northfield, Illinois-based medical-supplies giant, backed by Blackstone, Carlyle, and Hellman & Friedman, upsized the deal to meet robust institutional demand. Opening trades suggested the stock could gap higher on day one. But investors need to focus on some critica ...

Welcome to Morning Brief presented by Robin Hood, the home to commission free [music] trading. I'm Julie Hyman. Here's what we're watching today.First up, OpenAI is in talks to [music] raise $10 billion from Amazon. We'll have more on that report and what Amazon seeks to gain from that deal. Plus, as Micron prepares [music] to deliver its earnings after the bell, we'll break down the true cost of the artificial intelligence [music] buildout.And oil prices rebound after President Trump issues a complete bloc ...

So, let's get to KG on some of these top headlines and see what is driving the price action. And let's start with crude because we of course are tracking Trump's lines this morning about a blockade of these Venezuelan oil tankers. Just talk us through the significance of that story and the impact we're seeing on the markets this morning.KJ, >> yeah, you are seeing crude up about 1.3% so far. We actually did see a pullback here a tad bit. I mean the the supply glut narrative that's taking place in the market ...

Joining us right now first on CNBC is Medline CEO Jim Bole. Good morning to you. >> Good morning.>> Congratulations. This been this has been a quite a road for you to get to to this point. Uh why go public now.What's the what's what's the thinking in terms of where you came from and where you are right now. >> And as you know, we've been a private company for 58 years. Um with 58 years of consecutive growth, uh we just feel like this is the right time for us to kind of expand our voice.Historically, we've d ...

All right, welcome back to Worldwide Exchange. As we close on the 6 a. m.hour, a check on a few big stories that we're following this morning. Sources tell CNBC Open AI is in talks to raise at least $10 billion from Amazon and use its chips. Open AAI has so far declined to comment.A deal could value OpenAI at more than $500 billion and see it adopt Amazon's Tranium chip, a story that we're continue to follow throughout the morning. All right, Whimo is in talks to raise $15 billion in funding in the new year ...

All right, welcome back to Worldwide Exchange. As we close on the 6 a. m.hour, a check on a few big stories that we're following this morning. Sources tell CNBC Open AI is in talks to raise at least $10 billion from Amazon and use its [music] chips. Open AAI has so far declined to comment.A deal could value OpenAI [music] at more than $500 billion and see it adopt Amazon's Tranium chip, a story that we're continue to follow [music] throughout the morning. All right, Whimo is in talks to raise $15 billion in ...

Core Viewpoint - Medline is set to debut on the Nasdaq after raising $6.26 billion in the largest global initial public offering of 2025, marking a strong year for new listings [1] Group 1 - The IPO raised $6.26 billion, making it the biggest IPO globally in 2025 [1] - This event highlights a robust market for new listings in the current year [1]

NORTHFIELD, Ill., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) announced today the pricing of its upsized initial public offering of 216,034,482 shares of its Class A common stock, at a public offering price of $29.00 per share. Medline has granted the underwriters a 30-day option to purchase up to an additional 32,405,172 shares of Class A common stock. The shares are expected to begin trading on the Nasdaq Global Select Market on December 17, 2025, under the symbol “MDLN.” Medline intends to ...

Solventum received the Diamond Level Badge across all MedSurg product lines, including negative pressure wound therapy, advanced wound dressings, advanced skin care, IV site management, sterilization assurance, surgical solutions, hospital consumables and medical technologies OEM. SOURCE Solventum "Since our spinoff, we've worked tirelessly to strengthen every link on our supply chain—from demand planning to supplier partnerships—because our patients cannot wait," said Brent Boucher, senior vice president f ...